Susquehanna International Group, LLP Longeveron Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$2.52 - $4.0 $46,652 - $74,052
18,513 New
18,513 $62,000
Q1 2022

May 16, 2022
SELL
$5.06 - $13.8 $91,591 - $249,793
-18,101 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.92 - $42.3 $52,854 - $765,672
18,101 New
18,101 $218,000

Others Institutions Holding LGVN

# of Institutions
2
Shares Held
1.18K
Call Options Held
0
Put Options Held
0
View Full List

About Longeveron Inc.

LGVN Quotes by TradingView
  • Ticker LGVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,925,940
  • Market Cap $11.2M
  • Description
  • Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult ...
More about LGVN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email